{"name":"Jing Luo","slug":"jing-luo","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE51Q0hkSHlPWjFpdEIzQmlySFEzWURoN0JqOThiazQtUzJDLWk1djZtcXZBZkliMVBlVVZxck5TdUtuZDM3Vkd2SDBJLU5JeTRCMWxoakhQSWRUYXBCbTlUWmJXWQ?oc=5","date":"2026-01-08","type":"pipeline","source":"ACS Publications","summary":"Near-Infrared Chemiluminescence Probe for Superoxide Anion Imaging in Alzheimer’s Disease - ACS Publications","headline":"Near-Infrared Chemiluminescence Probe for Superoxide Anion Imaging in Alzheimer’s Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBCd2UzYkNSVEozWUxFYmhpaUlXM2NNNGtpdlI5T1c5dHNhQW1iaW1DbzZoTlFtWmx2dnBDVjcyckZiQTRpV3BRUkFVU0plOTdWeXZlZzU3V3ZnNEFXS3FiQzBWbm1vWjNnZjVYWHJ5M2pZUXUtMmFManZDMA?oc=5","date":"2022-11-24","type":"pipeline","source":"CBC","summary":"Writer says he posted 'insulin is free' tweet to make a point about corporate greed - CBC","headline":"Writer says he posted 'insulin is free' tweet to make a point about corporate greed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPbVNFSHFqRG1zOW5OT0dwR2NEdlZrNUFHb1BiMUh4VC1mVnJFOEcwa1FEOWRqci1KUURLM0w3Z1VudkVDZmIxaTdxQlNmNDItQnkwaXpfZzVDcC1nTEpoN3NhLXRvQXhkU1g2YUtUMFpJLVhkZWlyTWYzT2V2VE93VVFSQ0tDZ3BfX19WcjlvU1pjR0cwNUJhTTduSjVERVE2YjYwSzVZaWNPT3JqTmFlN3ZKNVhRakhFZ2NWTG9lYmVKRnFGNXNKTFh1SzBRVDA?oc=5","date":"2022-05-09","type":"earnings","source":"The Conversation","summary":"Nonprofit drugmaker Civica Rx is taking aim at the high insulin prices harming people with diabetes - The Conversation","headline":"Nonprofit drugmaker Civica Rx is taking aim at the high insulin prices harming people with diabetes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBSWjVJN0dBVk9ybDh5dFQ0WTZKS2gxcjFhM3VFT0NveHZpY1BIWTJ1ZV8tX2pSa1BXdktRb2JTY0tHaTVqZnBtVW8xaVFQaFFXM29tbjhPc0E3UlRLYnhJWGVCZDNjTTk5Tkw5SFNtRVpLVkUyeDhz?oc=5","date":"2020-09-30","type":"pipeline","source":"The Washington Post","summary":"Trump boasted he made insulin so cheap ‘it’s like water.’ Americans with diabetes beg to differ. - The Washington Post","headline":"Trump boasted he made insulin so cheap ‘it’s like water.’ Americans with diabetes beg to differ.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQR25jV1hxcHd1b3JUeWdENGpCXzU1NC1rWkwtZGg3alFZcmpCZ3VzTVlPZDFWX182Y1dZMU56aTBtTkRhVENxaXJMZGJ2RG1rQ0JYd0MtMUhEN1l4V1hreFJrbDRvSHlPUmZxWWhQXzVuTlZ2WkRKc0d0V0o0UGh4eEdHVzc3ZlN1QUVjbkVJdW1YZjJBcXBRZUJ4NUtVejFXSW55OVVYSS03SWV5N1VTd25pX0Njb3dxbE53eFVB?oc=5","date":"2019-11-01","type":"pipeline","source":"Healio","summary":"US pharmacies closing at high rate, potentially impacting patient health - Healio","headline":"US pharmacies closing at high rate, potentially impacting patient health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOaWJxYzRXa3BKamhDVHdJeXNCYnhBOVVQRnZlX1Z1aE1yendWRXNvOTRtd3pCWURobEs1V1Y1MVdEMjRuUW5iTllEdEtsNXNudkhRdGtoNV9pN2ttVTZheHJmYjRHMkd6a0Uwd3U2NExxTnVzdkRtMXRXM2NTRnZydU5NbURSU2ZoWF9CWDZ4MFE5NjgxRnBra1ZEVkxOamc?oc=5","date":"2017-03-28","type":"trial","source":"Fierce Pharma","summary":"Mylan's $465M settlement shortchanges taxpayers: study - Fierce Pharma","headline":"Mylan's $465M settlement shortchanges taxpayers: study","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}